Trial Profile
Effect of Pioglitazone Compared to a Combination Therapy With Ramipril and to a Ramipril Monotherapy on Low Grade Inflammation and Vascular Function in Patients With Increased Cardiovascular Risk and an Activated Inflammation. A Randomized Double-Blinded Phase II Study.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Pioglitazone (Primary) ; Ramipril
- Indications Hypertension; Insulin resistance
- Focus Pharmacodynamics
- Acronyms PIOace
- Sponsors Takeda Pharma
- 12 Jul 2011 New source identified and integrated (European Clinical Trials Database; EudraCT2006-004028-35).
- 22 Oct 2009 Results presented at the 20th World Diabetes Congress.
- 01 Oct 2009 Results presented at the 45th Annual Meeting of the European Association for the Study of Diabetes (EASD).